Agilent Technologies CEO Michael McMullen's 2022 pay rises 4% to $17M

Agilent Technologies reports 2022 executive compensation

By ExecPay News

Published: February 3, 2023

Agilent Technologies reported fiscal year 2022 executive compensation information on February 3, 2023.
In 2022, five executives at Agilent Technologies received on average a compensation package of $6.7M, a 8% increase compared to previous year.
Average pay of disclosed executives at Agilent Technologies
Michael R. McMullen, Chief Executive Officer, received $17M in total, which increased by 4% compared to 2021. 63% of McMullen's compensation, or $11M, was in stock awards. McMullen also received $2.3M in non-equity incentive plan, $2.5M in option awards, $1.3M in salary, as well as $82K in other compensation.
For fiscal year 2022, the median employee pay was $75,498 at Agilent Technologies. Therefore, the ratio of Michael R. McMullen's pay to the median employee pay was 221 to one.
Robert McMahon, Chief Financial Officer, received a compensation package of $4.8M, which increased by 2% compared to previous year. 55% of the compensation package, or $2.6M, was in stock awards.
Henrik Ancher-Jensen, Senior Vice President, President Order Fulfillment and Supply Chain, earned $4.5M in 2022.
Jacob Thaysen, Senior Vice President, President Life Sciences and Applied Markets Group, received $4.1M in 2022, which increases by 7% compared to 2021.
Sam Raha, Senior Vice President, President Diagnostics and Genomics Group, earned $3.4M in 2022, a 3% increase compared to previous year.
Agilent Technologies' fiscal year ends on October 31.

Related executives

Michael McMullen

Agilent Technologies

Chief Executive Officer

Robert McMahon

Agilent Technologies

Chief Financial Officer

Jacob Thaysen

Agilent Technologies

Senior Vice President, President Life Sciences and Applied Markets Group

Henrik Ancher-Jensen

Agilent Technologies

Senior Vice President, President Order Fulfillment and Supply Chain

Sam Raha

Agilent Technologies

Senior Vice President, President Diagnostics and Genomics Group

You may also like

Source: SEC filing on February 3, 2023.